首页> 美国卫生研究院文献>Journal of Virology >Broadly Neutralizing Monoclonal Antibodies 2F5 and 4E10 Directed against the Human Immunodeficiency Virus Type 1 gp41 Membrane-Proximal External Region Protect against Mucosal Challenge by Simian-Human Immunodeficiency Virus SHIVBa-L
【2h】

Broadly Neutralizing Monoclonal Antibodies 2F5 and 4E10 Directed against the Human Immunodeficiency Virus Type 1 gp41 Membrane-Proximal External Region Protect against Mucosal Challenge by Simian-Human Immunodeficiency Virus SHIVBa-L

机译:针对人类免疫缺陷病毒1型gp41膜近端外部区域的广泛中和单克隆抗体2F5和4E10可防止猿猴-人类免疫缺陷病毒SHIVBa-L对粘膜的攻击

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

The membrane-proximal external region (MPER) of HIV-1, located at the C terminus of the gp41 ectodomain, is conserved and crucial for viral fusion. Three broadly neutralizing monoclonal antibodies (bnMAbs), 2F5, 4E10, and Z13e1, are directed against linear epitopes mapped to the MPER, making this conserved region an important potential vaccine target. However, no MPER antibodies have been definitively shown to provide protection against HIV challenge. Here, we show that both MAbs 2F5 and 4E10 can provide complete protection against mucosal simian-human immunodeficiency virus (SHIV) challenge in macaques. MAb 2F5 or 4E10 was administered intravenously at 50 mg/kg to groups of six male Indian rhesus macaques 1 day prior to and again 1 day following intrarectal challenge with SHIVBa-L. In both groups, five out of six animals showed complete protection and sterilizing immunity, while for one animal in each group a low level of viral replication following challenge could not be ruled out. The study confirms the protective potential of 2F5 and 4E10 and supports emphasis on HIV immunogen design based on the MPER region of gp41.
机译:HIV-1的膜近端外部区域(MPER)位于gp41胞外域的C末端,是保守的,对于病毒融合至关重要。三种广泛中和的单克隆抗体(bnMAb)2F5、4E10和Z13e1针对映射到MPER的线性表位,使该保守区成为重要的潜在疫苗靶标。但是,尚未明确显示出MPER抗体可提供抗HIV攻击的保护。在这里,我们显示MAb 2F5和4E10都可以提供针对猕猴的粘膜猿猴-人类免疫缺陷病毒(SHIV)攻击的完整保护。在用SHIVBa-L进行直肠内攻击前1天和1天后,以50 mg / kg的剂量将单克隆抗体2F5或4E10静脉内给药于六只雄性印度恒河猴。在两组中,六只动物中有五只显示出完全的保护和杀菌免疫力,而每组中的一只动物则不能排除攻击后病毒复制水平低。该研究证实了2F5和4E10的保护潜力,并支持基于gp41的MPER区的HIV免疫原设计。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号